CHICAGO, Jan. 30, 2018 -- Typenex Medical, an industry leader in medical devices and supplies, today, announced it has launched FibernexTM, a line of single-use and reusable holmium laser fibers compatible with holmium and Nd:YAG laser systems with standard SMA-905 fiber connections. Fibernex holmium laser fibers can be used for a variety of surgical uses including open, laparoscopic or endoscopic ablation, coagulation, incision, excision and vaporization.
“We are excited to join the market leaders in this product space with our small business approach,” said John Fife, owner and chief executive officer (CEO), Typenex Medical. “We believe, by expanding into the urology market, we can offer our customers a wider variety of product solutions that improve costs and patient care.”
Fibernex offers healthcare providers a quality, cost-effective alternative to leading holmium laser fibers in the market today. Fibernex laser fibers are designed and manufactured with premium raw materials to ensure optimal fiber optic performance when in use. The fibers feature many characteristics to protect the scope during use. The 4-layer design matches the best-in-class products and features a Tefzel ® outer jacket to limit light emission and protect the scope. The rounded-tip design of the disposable fibers feature a polished edge to facilitate smooth introduction and minimize damage of the scope upon insertion.
Typenex Medical, a leading blood bank and laboratory supplier, branched out in the surgical supplies segment of the market in June of 2015. Since then, Typenex has launched 11 product lines for the surgical suite and gained considerable amount of market share in those categories.
About Typenex Medical:
Typenex Medical is a medical device and supply company founded by entrepreneur and investor, John Fife. The Typenex Medical advantage is connecting with customers to understand their process needs, then delivering simple, high-quality products that streamline workflows. Thinking about patient safety and comfort is a strength, along with efficiency and cost-effectiveness – all while providing a quality product. For more information please visit www.typenexmedical.com.
Contact: Lindsey Anderson Product Manager, OR 312-888-4058 [email protected]


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



